Covid19, Subcutaneous Emphysema
Conditions
Brief summary
Background Numerous surgicals treatments have been described for the massive subcutaneous emphysema; however, some of these techniques cannot be carried out in a critical care unit and they are related with high morbidity and exposure in positive SARS COV-2 patients. More effective, less invasive and isolated procedures should be implemented. Technique Negative pressure therapy (NPT) that can allow effective solving of massive subcutaneous emphysema in a short period (5 days) with a minimally invasive approach at the bedside in Covid-19 or non infected critical patients. Conclusion NPT is an effective and low invasive strategy for the management of EES in critical patients with high risk of mortality.
Interventions
VAC THERAPY vs SURGICAL DREINAGE
Sponsors
Study design
Eligibility
Inclusion criteria
* Subcutaneous emphysema that compromises ventilation
Exclusion criteria
* Declined Therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Resolution time of emphysema with negative pressure therapy | Days | Days |
Countries
Spain